M. Scaramozza

发表

Cognitive control of attention is differentially affected in trauma-exposed individuals with and without post-traumatic stress disorder

D. Pine, D. Charney, R. Blair, 2012, Psychological Medicine.

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis

D. Arnold, C. Elliott, G. Giovannoni, 2022, BMJ Neurology Open.

Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia

L. Boggio, S. Arkin, M. Mancuso, 2018, Journal of thrombosis and haemostasis : JTH.

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study

E. Peeva, M. Dowty, A. Banerjee, 2020, Clinical and translational science.

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF‐06700841) in Healthy Subjects and Patients With Plaque Psoriasis

K. Page, E. Peeva, M. Dowty, 2018, Journal of clinical pharmacology.

Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study

E. Peeva, J. Krueger, S. Garcet, 2021 .

Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis

C. Pozzilli, P. Vermersch, A. Maghzi, 2022, JAMA network open.

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

H. Hartung, G. Comi, S. Greenberg, 2013, Expert opinion on pharmacotherapy.

Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor, PF 06700841, Reveal Reduction of Skin Inflammation in Plaque Psoriasis: TYK2/JAK1 inhibitor in plaque psoriasis.

E. Peeva, M. Suárez-Fariñas, C. Banfield, 2020, The Journal of investigative dermatology.

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells

M. Mingueneau, Baohong Zhang, S. Belachew, 2021, Clinical & translational immunology.

Biased emotional attention in post-traumatic stress disorder: a help as well as a hindrance?

D. Pine, D. Charney, R. Blair, 2007, Psychological Medicine.

Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions

D. Arnold, E. Fisher, C. Elliott, 2020, American Journal of Neuroradiology.

Effect of Ceralifimod (ONO-4641), a Sphingosine-1-Phosphate Receptor-1 and -5 Agonist, on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis: Interim Results from the Extension of the DreaMS Study (P3.161)

A. Bar-Or, F. Zipp, T. Vollmer, 2014 .

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

P. Vermersch, H. Hartung, G. Comi, 2014, The Lancet Neurology.

Reward circuitry in resilience to severe trauma: An fMRI investigation of resilient special forces soldiers

G. Hazlett, S. Southwick, W. Drevets, 2009, Psychiatry Research: Neuroimaging.

Cognitive control of attention is differentially affected in trauma-exposed individuals with and without post-traumatic stress disorder

D. Pine, D. Charney, R. Blair, 2012, Psychological Medicine.

Reward circuitry in resilience to severe trauma: An fMRI investigation of resilient special forces soldiers

G. Hazlett, S. Southwick, W. Drevets, 2009, Psychiatry Research: Neuroimaging.